Trade

with

Discovery Laboratories Inc
(NASDAQ: DSCO)
AdChoices
1.93
+0.01
+0.52%
After Hours :
1.91
-0.02
-0.87%

Open

1.95

Previous Close

1.92

Volume (Avg)

143.39k (331.98k)

Day's Range

1.86-1.96

52Wk Range

1.51-2.77

Market Cap.

164.45M

Dividend Rate ( Yield )

-

Beta

1.66

Shares Outstanding

85.21M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 388.00k

    • Net Income

    • -45.22M

    • Market Cap.

    • 164.45M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -3,660.65

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.66

    • Forward P/E

    • -4.60

    • Price/Sales

    • 113.64

    • Price/Book Value

    • 4.19

    • Price/Cash flow

    • -3.57

      • EBITDA

      • -43.04M

      • Return on Capital %

      • -89.09

      • Return on Equity %

      • -164.40

      • Return on Assets %

      • -89.09

      • Book Value/Share

      • 0.46

      • Shares Outstanding

      • 85.21M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 5.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.42

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 500.50

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -39.02

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -61.29

            • 82.75

            • Pre-Tax Margin

            • -3,660.65

            • 39.38

            • Net Profit Margin

            • -3,660.65

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.49

              • 0.76

              • Current Ratio

              • 6.12

              • 2.92

              • Quick Ratio

              • 6.04

              • 2.35

              • Interest Coverage

              • -13.50

              • 38.02

              • Leverage Ratio

              • 1.77

              • 2.21

              • Book Value/Share

              • 0.46

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -3.12

                • 217.39

                • P/E Ratio 5-Year High

                • -25.22

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.33

                • 124.82

                • Price/Sales Ratio

                • 113.64

                • 9.52

                • Price/Book Value

                • 4.19

                • 8.61

                • Price/Cash Flow Ratio

                • -3.57

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -164.40

                        (-369.10)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -89.09

                        (-123.40)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -104.87

                        (-267.00)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 8.47

                      • 1.48

                      • Asset Turnover

                      • 0.02

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -44.51M
                      Operating Margin
                      -11,471.13
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -3.57
                      Ownership

                      Institutional Ownership

                      61.63%

                      Top 10 Institutions

                      51.56%

                      Mutual Fund Ownership

                      21.51%

                      Float

                      85.38%

                      5% / Insider Ownership

                      1.21%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Select Health Care Portfolio

                      •  

                        3,739,618

                      • 0.19

                      • 4.39

                      • Fidelity® Advisor Small Cap Opps Fund

                      •  

                        3,332,539

                      • 0.00

                      • 3.91

                      • Fidelity® Stock Selector Small Cap Fund

                      •  

                        1,566,863

                      • 0.00

                      • 1.84

                      • Turner Medical Sciences Long/Short

                      •  

                        1,425,423

                      • 89.36

                      • 1.67

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,421,499

                      • 0.00

                      • 1.67

                      • Turner Spectrum Fund

                      •  

                        1,046,097

                      • 59.09

                      • 1.23

                      • Fidelity Advisor® Health Care Fund

                      •  

                        797,500

                      • 0.19

                      • 0.94

                      • Vanguard Extended Market Index Fund

                      •  

                        755,154

                      • 2.92

                      • 0.89

                      • Fidelity® Large Cap Stock Fund

                      •  

                        638,886

                      • 0.49

                      • 0.75

                      • Fidelity VIP Health Care Portfolio

                      •  

                        505,504

                      • 0.14

                      • 0.59

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity Management and Research Company

                      •  

                        12,639,199

                      • +0.41%

                      • 14.83

                      • Broadfin Capital, LLC

                      •  

                        8,066,000

                      • 0.00%

                      • 9.47

                      • Dafna Capital Management LLC

                      •  

                        5,698,739

                      • 0.00%

                      • 6.69

                      • Deerfield Management Co

                      •  

                        3,659,700

                      • 0.00%

                      • 4.29

                      • Baker Bros Advisors LLC

                      •  

                        3,652,117

                      • 0.00%

                      • 4.29

                      • BlackRock Fund Advisors

                      •  

                        2,363,914

                      • +4.65%

                      • 2.77

                      • Wellington Management Company, LLP

                      •  

                        2,144,485

                      • 0.00%

                      • 2.52

                      • Vanguard Group, Inc.

                      •  

                        2,003,276

                      • +0.53%

                      • 2.35

                      • Alyeska Investment Group, L.P.

                      •  

                        1,956,841

                      • +8.13%

                      • 2.30

                      • Millennium Management LLC

                      •  

                        1,750,000

                      • +21.83%

                      • 2.05

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Discovery Laboratories Inc was incorporated as a Delaware corporation in 1992. The Company is a specialty biotechnology company engaged in creating life-saving products for critical-care patients with respiratory disease and improvin...moreg the standard of care in pulmonary medicine. Its proprietary drug technology produces a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to pulmonary surfactant, a substance produced naturally in the lung and essential for normal respiratory function and survival. The Company is developing its KL4 surfactant in liquid, lyophilized and aerosolized dosage forms. IT is also developing novel drug delivery technologies potentially to enable efficient delivery of its aerosolized KL4 surfactant. The Company is initially engaged in improvin...moreg the management of respiratory distress syndrome (RDS) in premature infants. It has developed a disposable aerosol-conducting airway connector for infants that is intended to simplify the delivery of aerosolized medications and other inhaled therapies to critical-care patients requiring ventilatory support. The Company has exclusive rights to its CAG technology for use with pulmonary surfactants for all respiratory diseases and conditions. In addition, it hold in the U.S. exclusive rights to the CAG technology for use with certain non-surfactant drugs to treat various pediatric and adult respiratory indications in hospitals and other health care institutions. It has also developed a novel, disposable aerosol-conducting airway connector that is intended to simplify the delivery of aerosolized medications, including its aerosolized KL4 surfactant, and inhaled therapies to infants requiring ventilatory support in the NICU and PICU. AEROSURF, AFECTAIR, AFECTAIR DUO, DISCOVERYLABS, SURFAXIN, SURFAXIN LS, and WARMING CRADLE are the Company’s registered and common law trademarks. The Company’s development, manufacture, distribution, marketing and advertising of drug, device, and combination drug-device products are subject to extensive regulation by federal, state and local governmental authorities in the U.S., including the FDA, and by similar agencies in other countries.lessless

                      Key People

                      John G. Cooper

                      CEO/Director/President

                      John R. Leone

                      Chairman of the Board/Director

                      Mr. John Tattory

                      CFO/Chief Accounting Officer/Senior VP

                      Mr. William C. Roberts

                      Vice President, Divisional

                      Thomas Hoy

                      Vice President, Divisional

                      • Discovery Laboratories Inc

                      • 2600 Kelly Road

                      • Warrington, PA 18976-3622

                      • USA.Map

                      • Phone: +1 215 488-9300

                      • Fax: +1 215 488-9301

                      • discoverylabs.com

                      Incorporated

                      1992

                      Employees

                      126

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: